P.34 Business Section
Article: In the Hunt for some elusive little sparklers (three companies featured- Invion third). Tim Boreham
Article Discusses the implications of the "notice of allowance" released midweek concerning Chinese patent affirmation.
GC says "it's a small announcement that adds to the bigger story".
"Collier says that its intention is not to apply for Chinese marketing approval but to use its affirmation to bolster its case for the FDA. "
The article then goes on to discuss the capital raising last year that was "panned" for allowing US backers to acquire 30% of the register within 5 years. "Collier concedes they 'raised capital at lower levels than they would have liked' but in essence had no choice."
Paragraph then about position results of phase 2 trials.
Concluding paragraph: "a company with a promising drug, but with the high chance of its shareholders not enjoying the spoils. Don't call the Quit line on this one yet."
IVX Price at posting:
0.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)